Karen Vousden, Ph.D.
Board Member
Faeth Therapeutics, Inc. (FTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen Vousden, Ph.D.
Karen Vousden, Ph.D. is recorded as Board Member at Faeth Therapeutics, Inc. (FTH). Faeth Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that Karen Vousden, Ph.D. was appointed Class II director, effective September 11, 2026.
“On September 11, 2026, the Board of Directors (the "Board") of Faeth Therapeutics, Inc. (the "Company") increased the size of the Board from five to six directors and appointed Karen Vousden, Ph.D. to serve as a Class II director, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Faeth Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anand Parikh CEO, Chairman, COO, Board Member
- John Celebi CEO, Board Member
- William Ringo Chairman, Board Member
- Brian Stephenson CFO
- Josiah Craver CFO, Chief Accounting Officer
- Christopher W. Gerry General Counsel, Board Member
- Bob Holmen Board Member
- Kristian Humer Board Member
- Phillip B. Donenberg Board Member
- Saira Ramasastry Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.